Delaware | 1-31719 | 13-4204626 | |||
(State of incorporation) | (Commission File Number) | (I.R.S. Employer Identification | |||
Number) |
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
|_| Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|_| Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|_|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b))
|_|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
240.13e-4(c))
Attached as Exhibit 99.1 to this
report is a copy of the presentation made by Molina Healthcare, Inc. and broadcast live at the UBS Global
Healthcare Services Conference in New York City on February 14, 2005. A replay of the live broadcast
is available on Molina Healthcare's website at www.molinahealthcare.com. (c) Exhibits: Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused
this report to be signed on its behalf by the undersigned hereunto duly authorized.
Item 8.01 Other Events.
Item 9.01 Financial
Statements and Exhibits.
Exhibit
No.
Description
99.1
Presentation to the UBS Global Healthcare Services Conference.
SIGNATURE
Date: February 18, 2005
MOLINA HEALTHCARE, INC.
By: /s/ Mark L. Andrews
Mark L. Andrews
Executive Vice President,
General Counsel, and Corporate Secretary
EXHIBIT INDEX
Exhibit
No.
Description
99.1
Presentation by Molina Healthcare at UBS Global Healthcare Services Conference in New York City on February 14, 2005.